Harvard Bioscience Q4 Sales $23.735M Beat $23.100M Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings BeatsNews
Harvard Bioscience (NASDAQ:HBIO) reported quarterly sales of $23.735 million which beat the analyst consensus estimate of $23.100 million by 2.75 percent. This is a 3.34 percent decrease over sales of $24.556 million
Harvard Bioscience (NASDAQ:HBIO) reported quarterly sales of $23.735 million which beat the analyst consensus estimate of $23.100 million by 2.75 percent. This is a 3.34 percent decrease over sales of $24.556 million the same period last year.